Skip to main content

Table 1 Baseline characteristics of the two groups

From: The application value of serum 25(OH)D3, uric acid, triglyceride, and homeostasis model assessment of insulin resistance in male patients with hyperuricemia combined with hypogonadism

Items

Normal group

(n = 117)

Hypogonadism group

(n = 81)

t/χ2

P value

Age (years, mean ± SD)

56.8 ± 5.82

56.7 ± 5.69

0.132

0.895

Course of disease (years, mean ± SD)

5.26 ± 0.36

5.22 ± 0.45

0.666

0.506

BMI (kg/m2, mean ± SD)

25.11 ± 1.33

26.22 ± 1.15

-6.609

<0.001

WC (cm, mean ± SD)

94.01 ± 4.39

96.69 ± 4.23

-4.287

<0.001

SBP (mmHg, mean ± SD)

132 ± 14

135 ± 12

-1.57

0.118

DBP (mmHg, mean ± SD)

84 ± 8

86 ± 9

-1.643

0.102

GA, n ( %)

9 (7.69)

8 (9.88)

0.291

0.59

CHD, n ( %)

7 (5.98)

5 (6.17)

0.003

0.956

Hypertension, n ( %)

60 (51.28)

43 (53.09)

0.062

0.803

T2DM, n ( %))

15 (12.82)

11 (13.58)

0.024

0.877

NAFLD, n ( %)

27 (23.08)

39 (48.15)

13.538

<0.001

HLP, n ( %)

48 (49.57)

58 (59.26)

17.993

<0.001

OB, n ( %)

39 (40.17)

47 (48.15)

11.877

<0.001

Smoking history, n ( %)

23 (19.66)

17 (20.99)

0.052

0.82

Drinking history, n ( %)

36 (30.77)

26 (32.10)

0.039

0.843

  1. BMI body mass index; WC waist circumference; SBP systolic blood pressure; DBP diastolic blood pressure; GA gouty arthritis; CHD coronary heart disease: T2DM type 2 diabetes mellitus; NAFLD non-alcoholic fatty liver disease; HLP hyperlipidaemia; OB obesity